Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2026-03-21 @ 4:46 AM
Study NCT ID:
NCT01145404
Status:
TERMINATED
Last Update Posted:
2014-07-02
First Post:
2010-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal Cancer
Sponsor:
National Center for Tumor Diseases, Heidelberg
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NCT-2008-11-01-1015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None